4.3 Article

Aging in fragile X syndrome

Journal

JOURNAL OF NEURODEVELOPMENTAL DISORDERS
Volume 2, Issue 2, Pages 70-76

Publisher

SPRINGER
DOI: 10.1007/s11689-010-9047-2

Keywords

Aging; Fragile X syndrome; Medical problems; Movement disorder

Funding

  1. NICHD [HD036071, HD02274, HD055510]
  2. NIA [AG032115]
  3. Administration for Developmental Disabilities [90DD05969]
  4. Spastic Paralysis and Allied Diseases of the Central Nervous System Research Foundation of The Illinois-Eastern Iowa District Kiwanis International
  5. Colorado IDDRC
  6. BPKLN, Ministry of National Education, Government of Indonesia
  7. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071, P30HD002274] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE ON AGING [RL1AG032115] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Many studies have focused on the behavior and cognitive problems in young patients with fragile X syndrome (FXS), but there are no studies about the problems in aging for those with FXS. The discovery of the fragile X-associated tremor ataxia syndrome (FXTAS), a neurodegenerative disorder related to elevated FMR1-mRNA, in elderly men and some women with the premutation, intensified the need for aging studies in FXS. Approximately 40% of males with FXS have repeat size mosaicism and as a result, some of these individuals also have elevated levels of FMR1-mRNA which theoretically puts them at risk for FXTAS. Here, we have surveyed all of the aging patients with FXS that we have followed over the years to clarify the medical complications of aging seen in those with FXS. Data was collected from 62 individuals with the FXS full mutation (44 males; 18 females) who were at least 40 years old at their most recent clinical examination. We found that the five most frequent medical problems in these patients were neurological problems (38.7%), gastrointestinal problems (30.6%), obesity (28.8%), hypertension (24.2%) and heart problems (24.2%). Movement disorders were significantly different between males and females (38.6% vs. 10.2%, p=0.029). We did not find any differences in medical problems between those with a full mutation and those with mosaicism. Identification of medical problems associated with aging in FXS is important to establish appropriate recommendations for medical screening and treatment considerations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available